Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Everjoy Health Group Co., Ltd. (002162.SZ)
Shanghai, CN
Everjoy Health Group Co., Ltd. is primarily involved in the complete lifecycle of ceramic tiles within China, encompassing their conceptualization, manufacturing, and market distribution. Additionally, the firm diversifies its portfolio by offering medical and retirement care provisions. It further engages in the acquisition and rental of real estate assets. The company's origins trace back to 1993, with its operational headquarters situated in Shanghai, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.79% | -5.43% | -14.70% | -31.24% | -24.01% | -17.81% | -6.81% | -3.53% | -50.07% | -40.80% | -48.75% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Construction: +2.5%-11.8% Q1'26: +7.6% (vs Q1'25)
-
EPS growth Construction: +11.1%+104.9% ★ Q1'26: +58.9% (vs Q1'25)
-
FCF margin FCF growth · Construction: +30.9%+0.1% Q1'26: -6.4% (vs Q1'25)
-
EBIT margin Construction: +8.5%+2.9% Q1'26: +0.1% (vs Q1'25)
-
ROIC Construction: +6.4%+1.8% Q1'26: +0.1% (vs Q1'25)
-
Share dilution Construction: +0.4%-6.7% ★ Q1'26: -0.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Construction: 0.05×5.98× Q1'26: 911.42× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
|---|---|---|
| Revenue |
977.88M
est: 1.07B (-8.6%)
|
1.17B
est: 1.12B (+3.9%)
|
| EBITDA |
135.08M
est: 49.24M (+174.3%)
|
167.41M
est: 51.68M (+223.9%)
|
| EBIT |
72.83M
est: -12.73M (+672.0%)
|
99.42M
est: -13.36M (+844.0%)
|
| Net Income |
24.35M
|
37.87M
|
| SGA |
248.47M
est: 208.28M (+19.3%)
|
286.96M
est: 218.60M (+31.3%)
|
| EPS |
0.03
|
0.04
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-25 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C+ | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C+ | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chao Chen | Executive Vice President & Director | — | female |
| Chi Ming | Vice President | — | male |
| Hui Liu | Vice President | — | male |
| Lu Wang | Vice President | — | male |
| Mei Cheng | Board Secretary | — | female |
| Qian Chen | Executive Vice President & Director | — | male |
| Yifei Zhao | Chief Financial Officer | — | male |
| Yuancheng Song | Vice President & Director | — | male |
| Zhiming He | Executive Vice President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002162.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
